Brian C. Stephenson - 03 Feb 2023 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Secretary, Treasurer & CFO
Signature
/s/ Brian C. Stephenson
Issuer symbol
BBIO
Transactions as of
03 Feb 2023
Net transactions value
-$671,922
Form type
4
Filing time
06 Feb 2023, 18:43:51 UTC
Previous filing
06 Jan 2023
Next filing
21 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Sale $671,922 -61,040 -22% $11.01 219,184 03 Feb 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 6, 2022.
F2 Represents the weighted average sale price of the shares sold from $10.61 to $11.26 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.